Cleared Traditional

K803133 - RUBELLA VIRUS SEROLOGICAL REAGENT RUBEL

K803133 is an FDA 510(k) clearance for RUBELLA VIRUS SEROLOGICAL REAGENT RUBEL, manufactured by Microbiological Research Corp.. The device is a Class 2 Microbiology device with product code LFX cleared through the Traditional 510(k) pathway after a 48-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1981
Decision
48d
Days
Class 2
Risk

K803133 is an FDA 510(k) clearance for the RUBELLA VIRUS SEROLOGICAL REAGENT RUBEL. Classified as Enzyme Linked Immunoabsorbent Assay, Rubella (product code LFX), Class II - Special Controls.

Submitted by Microbiological Research Corp. (Mchenry, US). The FDA issued a Cleared decision on January 29, 1981 after a review of 48 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3510 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K803133

510(k) Number K803133 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 12, 1980
Decision Date January 29, 1981
Days to Decision 48 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
54d faster than avg
Panel avg: 102d · This submission: 48d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LFX Device Classification - Class 2, Special Controls

Product Code LFX Enzyme Linked Immunoabsorbent Assay, Rubella
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 866.3510
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Microbiology devices follow this clearance model.

Regulatory Peers - LFX Enzyme Linked Immunoabsorbent Assay, Rubella

All 93
Devices cleared under the same product code (LFX) and FDA review panel - the closest regulatory comparables to K803133.
RUBELLA RQ BIO-ENZABEAD KIT
K821804 · Litton Bionetics · Sep 1982
ENZYGNOST TM RUBELLA IGM
K813493 · Calbiochem-Behring Corp. · Mar 1982
EIA RUBELLA
K812787 · Gilford · Nov 1981
RUBELLA VIRUS SEROLOGICAL REAGENTS
K803175 · Microbiological Research Corp. · Jan 1981
ROTAZYME
K791746 · Abbott Laboratories · Nov 1979